QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026)
QuidelOrtho recorded quarterly Liabilities and Shareholders Equity of $5.6 billion in Q1 2026, down 2.44% quarter-over-quarter from $5.8 billion in Q4 2025, and down 12.89% year-over-year from $6.5 billion in Q1 2025.
QuidelOrtho's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $5.6 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 12.89% year-over-year to $5.6 billion; the TTM figure through Mar 2026 stood at $23.5 billion (down 11.08% YoY), while the FY2025 annual figure was $5.8 billion, down 10.19% from the prior year.
- Liabilities and Shareholders Equity came in at $5.6 billion for Q1 2026 at QuidelOrtho, down from $5.8 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.9 billion in Q1 2023 to a low of $2.4 billion in Q1 2022.
- A 5-year average of $7.0 billion and a median of $6.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity soared 264.38% in 2023 and declined 24.99% in 2024, its largest moves.
- QuidelOrtho's Liabilities and Shareholders Equity stood at $8.7 billion in 2022, then retreated by 1.07% to $8.6 billion in 2023, then declined by 24.99% to $6.4 billion in 2024, then slipped by 10.19% to $5.8 billion in 2025, then fell by 2.44% to $5.6 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $5.6 billion, $5.8 billion, and $5.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | QuidelOrtho | 898.19 Mn | 757.79 Mn | - | 5.63 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 5.63 Bn |
| Dec 28, 2025 | 5.77 Bn |
| Sep 28, 2025 | 5.68 Bn |
| Jun 29, 2025 | 6.38 Bn |
| Mar 30, 2025 | 6.46 Bn |
| Dec 29, 2024 | 6.42 Bn |
| Sep 29, 2024 | 6.80 Bn |
| Jun 30, 2024 | 6.69 Bn |
| Mar 31, 2024 | 6.70 Bn |
| Dec 31, 2023 | 8.56 Bn |
| Oct 1, 2023 | 8.54 Bn |
| Jul 2, 2023 | 8.55 Bn |
| Apr 2, 2023 | 8.79 Bn |
| Jan 1, 2023 | 8.86 Bn |
| Oct 2, 2022 | 8.66 Bn |
| Jul 3, 2022 | 8.82 Bn |
| Jan 2, 2022 | 2.43 Bn |